Surgery Partners Breaks Above 200-Day Moving Average - Bullish for SGRY
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Aug 13 2025
0mins
Should l Buy SGRY?
Source: NASDAQ.COM
Stock Performance Overview: SGRY's stock has a 52-week low of $18.87 and a high of $33.97, with the last trade recorded at $23.74.
Author's Perspective Disclaimer: The opinions expressed in the article are those of the author and do not necessarily represent Nasdaq, Inc.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy SGRY?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on SGRY
Wall Street analysts forecast SGRY stock price to rise
11 Analyst Rating
8 Buy
3 Hold
0 Sell
Moderate Buy
Current: 15.490
Low
18.00
Averages
26.30
High
36.00
Current: 15.490
Low
18.00
Averages
26.30
High
36.00
About SGRY
Surgery Partners, Inc. is a healthcare services company. The Company, through its subsidiaries, owns and operates a national network of surgical facilities and ancillary services. The Company operates through the Surgical Facility Services segment, which includes the operation of ambulatory surgery centers (ASCs), surgical hospitals, anesthesia services, urgent care facilities and multi-specialty physician practices. Its surgical facilities primarily provide non-emergency surgical procedures across many specialties, including, among others, orthopedics and pain management, ophthalmology, gastroenterology (GI) and general surgery. The Company operates a portfolio of 162 surgical facilities comprised of 143 ASCs and 19 surgical hospitals. The Company is focused on surgical services businesses in the United States, with over 250 locations in 30 states, including short-stay surgical hospitals.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Surgery Partners Announces $425 Million Private Debt Offering Pricing
Private Offering Announcement: Surgery Partners (SGRY) announced that its Surgery Center subsidiary has priced a private offering.
Financial Implications: The details regarding the amount raised and the intended use of proceeds from the offering were not specified in the announcement.
See More
Surgery Partners Prices $425 Million Senior Unsecured Notes Offering
- Bond Offering Size: Surgery Partners' wholly-owned subsidiary, Surgery Center Holdings, Inc., has successfully priced $425 million of 7.250% senior unsecured notes, expected to close on December 16, 2025, enhancing the company's financing flexibility.
- Clear Use of Proceeds: The net proceeds from this bond offering will be utilized for general corporate purposes, including repaying outstanding borrowings under its revolving credit facility, thereby optimizing the company's capital structure and reducing financial costs.
- Market Positioning: As a leading healthcare services company in the U.S., Surgery Partners operates over 200 locations across 30 states, continuously expanding its surgical services business to provide high-quality, cost-effective solutions for patients and physicians.
- Compliance and Risk Advisory: This bond offering complies with Rule 144A of the Securities Act, targeting only qualified institutional buyers, and the unregistered securities may face liquidity risks, necessitating attention to market changes that could impact the company's finances.
See More
Surgery Partners Prices $425 Million Senior Unsecured Notes Offering
- Bond Offering Size: Surgery Partners' subsidiary, Surgery Center Holdings, Inc., successfully priced $425 million of 7.250% senior unsecured notes, expected to close on December 16, 2025, enhancing the company's capital structure to support future growth.
- Clear Use of Proceeds: The net proceeds from this offering will be utilized for general corporate purposes, including repaying outstanding borrowings under its revolving credit facility, thereby optimizing the company's financial position and reducing interest burdens.
- Market Positioning: This bond issuance continues the company's strategy following the initial $800 million offering of similar notes in April 2024, indicating ongoing expansion and financing capabilities in the healthcare services sector.
- Compliance Assurance: The notes are being offered only to persons reasonably believed to be
See More
Surgery Partners Lowers Full-Year Revenue Guidance, Stock Plummets 25.42%
- Revenue Guidance Cut: Surgery Partners has lowered its full-year revenue guidance to a range of $3.275 billion to $3.3 billion, primarily due to delays in capital deployment and lost earnings from divestitures, indicating significant uncertainty in the company's market position.
- EBITDA Forecast Adjustment: The adjusted EBITDA guidance has been revised down to between $535 million and $540 million, reflecting a cautious outlook on the commercial payer mix and volume in Q4, which may impact future profitability.
- Stock Price Plunge: Following the earnings report on November 10, Surgery Partners' stock price fell by $5.47, or 25.42%, closing at $16.04 per share, demonstrating strong investor concern regarding the company's outlook.
- Legal Investigation Initiated: Pomerantz LLP is investigating whether Surgery Partners and its executives engaged in securities fraud or other unlawful business practices, potentially leading to further legal risks and financial repercussions.
See More
Surgery Partners Unveils $425 Million Additional Senior Notes Offering
Surgery Partners' Note Issuance: Surgery Partners, Inc. plans to issue an additional $425 million in 7.250% senior unsecured notes due 2032 through its subsidiary, Surgery Center Holdings, Inc., contingent on market conditions.
Use of Proceeds: The net proceeds from the note issuance will be utilized for general corporate purposes, including the repayment of outstanding borrowings under its revolving credit facility.
See More
Surgery Partners Forms Joint Venture with Baylor Scott & White to Enhance Local Surgical Care
- Partnership Expansion: Surgery Partners announces a joint venture with Baylor Scott & White Health, Texas's largest not-for-profit health system, to jointly own a 16-bed hospital in Bryan, aimed at enhancing local patient care quality.
- Continuity of Care: The new hospital will operate under the Baylor Scott & White name, allowing patients to continue receiving care in a familiar setting, thereby increasing patient satisfaction and loyalty.
- Diverse Services: The facility offers a wide range of surgical options, including bariatric, ophthalmologic, oral/maxillofacial, and orthopedic surgeries, further enriching Baylor Scott & White's surgical offerings in the College Station region.
- Strategic Growth: This partnership not only enhances the hospital's service capabilities but also provides Surgery Partners with opportunities to attract new physician partners, thereby expanding its influence in the rapidly growing healthcare market.
See More
Surgery Partners Announces $425 Million Private Debt Offering Pricing
Private Offering Announcement: Surgery Partners (SGRY) announced that its Surgery Center subsidiary has priced a private offering.
Financial Implications: The details regarding the amount raised and the intended use of proceeds from the offering were not specified in the announcement.
See More
Surgery Partners Prices $425 Million Senior Unsecured Notes Offering
- Bond Offering Size: Surgery Partners' wholly-owned subsidiary, Surgery Center Holdings, Inc., has successfully priced $425 million of 7.250% senior unsecured notes, expected to close on December 16, 2025, enhancing the company's financing flexibility.
- Clear Use of Proceeds: The net proceeds from this bond offering will be utilized for general corporate purposes, including repaying outstanding borrowings under its revolving credit facility, thereby optimizing the company's capital structure and reducing financial costs.
- Market Positioning: As a leading healthcare services company in the U.S., Surgery Partners operates over 200 locations across 30 states, continuously expanding its surgical services business to provide high-quality, cost-effective solutions for patients and physicians.
- Compliance and Risk Advisory: This bond offering complies with Rule 144A of the Securities Act, targeting only qualified institutional buyers, and the unregistered securities may face liquidity risks, necessitating attention to market changes that could impact the company's finances.
See More
Surgery Partners Prices $425 Million Senior Unsecured Notes Offering
- Bond Offering Size: Surgery Partners' subsidiary, Surgery Center Holdings, Inc., successfully priced $425 million of 7.250% senior unsecured notes, expected to close on December 16, 2025, enhancing the company's capital structure to support future growth.
- Clear Use of Proceeds: The net proceeds from this offering will be utilized for general corporate purposes, including repaying outstanding borrowings under its revolving credit facility, thereby optimizing the company's financial position and reducing interest burdens.
- Market Positioning: This bond issuance continues the company's strategy following the initial $800 million offering of similar notes in April 2024, indicating ongoing expansion and financing capabilities in the healthcare services sector.
- Compliance Assurance: The notes are being offered only to persons reasonably believed to be
See More
Surgery Partners Lowers Full-Year Revenue Guidance, Stock Plummets 25.42%
- Revenue Guidance Cut: Surgery Partners has lowered its full-year revenue guidance to a range of $3.275 billion to $3.3 billion, primarily due to delays in capital deployment and lost earnings from divestitures, indicating significant uncertainty in the company's market position.
- EBITDA Forecast Adjustment: The adjusted EBITDA guidance has been revised down to between $535 million and $540 million, reflecting a cautious outlook on the commercial payer mix and volume in Q4, which may impact future profitability.
- Stock Price Plunge: Following the earnings report on November 10, Surgery Partners' stock price fell by $5.47, or 25.42%, closing at $16.04 per share, demonstrating strong investor concern regarding the company's outlook.
- Legal Investigation Initiated: Pomerantz LLP is investigating whether Surgery Partners and its executives engaged in securities fraud or other unlawful business practices, potentially leading to further legal risks and financial repercussions.
See More
Surgery Partners Unveils $425 Million Additional Senior Notes Offering
Surgery Partners' Note Issuance: Surgery Partners, Inc. plans to issue an additional $425 million in 7.250% senior unsecured notes due 2032 through its subsidiary, Surgery Center Holdings, Inc., contingent on market conditions.
Use of Proceeds: The net proceeds from the note issuance will be utilized for general corporate purposes, including the repayment of outstanding borrowings under its revolving credit facility.
See More
Surgery Partners Forms Joint Venture with Baylor Scott & White to Enhance Local Surgical Care
- Partnership Expansion: Surgery Partners announces a joint venture with Baylor Scott & White Health, Texas's largest not-for-profit health system, to jointly own a 16-bed hospital in Bryan, aimed at enhancing local patient care quality.
- Continuity of Care: The new hospital will operate under the Baylor Scott & White name, allowing patients to continue receiving care in a familiar setting, thereby increasing patient satisfaction and loyalty.
- Diverse Services: The facility offers a wide range of surgical options, including bariatric, ophthalmologic, oral/maxillofacial, and orthopedic surgeries, further enriching Baylor Scott & White's surgical offerings in the College Station region.
- Strategic Growth: This partnership not only enhances the hospital's service capabilities but also provides Surgery Partners with opportunities to attract new physician partners, thereby expanding its influence in the rapidly growing healthcare market.
See More
